Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1976 2
1977 1
1979 1
1983 2
1984 1
1985 1
1988 1
1992 2
1995 3
1996 1
1997 2
1999 1
2000 4
2001 1
2002 4
2003 2
2004 2
2005 6
2006 4
2007 2
2008 6
2009 8
2010 3
2011 9
2012 10
2013 12
2014 10
2015 3
2016 12
2017 7
2018 7
2019 5
2020 14
2021 22
2022 19
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Targeting BCR-ABL1-positive leukaemias: a review article.
Leak S, Horne GA, Copland M. Leak S, et al. Among authors: copland m. Camb Prism Precis Med. 2023 Mar 6;1:e21. doi: 10.1017/pcm.2023.9. eCollection 2023. Camb Prism Precis Med. 2023. PMID: 38550948 Free PMC article. Review.
Leukaemia exposure alters the transcriptional profile and function of BCR::ABL1 negative macrophages in the bone marrow niche.
Dawson A, Zarou MM, Prasad B, Bittencourt-Silvestre J, Zerbst D, Himonas E, Hsieh YC, van Loon I, Blanco GR, Ianniciello A, Kerekes Z, Krishnan V, Agarwal P, Almasoudi H, McCluskey L, Hopcroft LEM, Scott MT, Baquero P, Dunn K, Vetrie D, Copland M, Bhatia R, Coffelt SB, Tiong OS, Wheadon H, Zanivan S, Kirschner K, Helgason GV. Dawson A, et al. Among authors: copland m. Nat Commun. 2024 Feb 5;15(1):1090. doi: 10.1038/s41467-024-45471-0. Nat Commun. 2024. PMID: 38316788 Free PMC article.
A randomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.
Copland M, Ariti C, Thomas IF, Upton L, Sydenham M, Mehta P, Islam S, Kjeldsen L, Burnett AK, Hills RK, Russell N, Dennis M; UK NCRI AML Study Group. Copland M, et al. Br J Haematol. 2024 Mar;204(3):871-876. doi: 10.1111/bjh.19220. Epub 2023 Nov 28. Br J Haematol. 2024. PMID: 38016651 Free article.
Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies.
Nicosia L, Spencer GJ, Brooks N, Amaral FMR, Basma NJ, Chadwick JA, Revell B, Wingelhofer B, Maiques-Diaz A, Sinclair O, Camera F, Ciceri F, Wiseman DH, Pegg N, West W, Knurowski T, Frese K, Clegg K, Campbell VL, Cavet J, Copland M, Searle E, Somervaille TCP. Nicosia L, et al. Among authors: copland m. Cancer Cell. 2023 Dec 11;41(12):2136-2153.e13. doi: 10.1016/j.ccell.2023.11.001. Epub 2023 Nov 22. Cancer Cell. 2023. PMID: 37995682 Free article.
The authors reply.
Angriman F, Muttalib F, Lamontagne F, Adhikari NKJ; LOVIT Investigators. Angriman F, et al. Crit Care Med. 2023 Dec 1;51(12):e283-e284. doi: 10.1097/CCM.0000000000006054. Epub 2023 Nov 16. Crit Care Med. 2023. PMID: 37971352 No abstract available.
201 results